Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Helping Behavior × Triptorelin Pamoate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 51 Breast Neoplasms 11 Polycystic Ovary Syndrome 9 Infertility 7 Ovarian Hyperstimulation Syndrome 3 Lymphoma 3 Sarcoma, Ewing 2 Sarcoma 2 Prostate Adenocarcinoma 2 Osteosarcoma 2 Neoplasms 2 Uterine Anomalies 1 The Neoadjuvant Therapy 1 Sleep Wake Disorders 1 Salpingitis 1 Salivary Gland Neoplasms 1 Primary Ovarian Insufficiency 1 Pregnancy, Ectopic 1 Neoplasm Metastasis 1 Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1 Myofibroma 1 Metabolic Syndrome 1 Leiomyoma 1 Infertility, Female 1 Hypogonadism 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Helping Behavior 1 Fatty Liver 1 Fatigue 1

Interventions

follitropin alfa 1 Urofollitropin 1 Triptorelin Pamoate 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04616729 2023-05-18

Depo-Trigger

Universitair Ziekenhuis Brussel

Phase 1/2 Unknown

Helping Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡